XML 41 R24.htm IDEA: XBRL DOCUMENT v3.3.0.814
EARNINGS PER SHARE (Tables)
 9 Months Ended
Sep. 30, 2015
Earnings Per Share, Basic and Diluted [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):

 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2015
 
2014
 
2015
 
2014
Amounts attributable to Quest Diagnostics’ stockholders:
 

 
 

 
 

 
 

Net income attributable to Quest Diagnostics
$
342

 
$
129

 
$
521

 
$
366

Less: Earnings allocated to participating securities
2

 
1

 
3

 
2

 
 
 
 
 
 
 
 
Earnings available to Quest Diagnostics’ common stockholders – basic and diluted
$
340

 
$
128

 
$
518

 
$
364

 
 
 
 
 
 
 
 
Weighted average common shares outstanding – basic
144

 
145

 
144

 
144

Effect of dilutive securities:
 

 
 

 
 

 
 

Stock options and performance share units
1

 
—

 
1

 
1

 
 
 
 
 
 
 
 
Weighted average common shares outstanding – diluted
145

 
145

 
145

 
145

 
 
 
 
 
 
 
 
Earnings per share attributable to Quest Diagnostics’ common stockholders:
 

 
 

 
 

 
 

Basic
$
2.37

 
$
0.89

 
$
3.61

 
$
2.52

 
 
 
 
 
 
 
 
Diluted
$
2.35

 
$
0.88

 
$
3.58

 
$
2.51
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect (shares in millions):
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2015
 
2014
 
2015
 
2014
Stock options and performance share units
2

 
—

 
2

 
3